At a glance
- Originator Nonindustrial source
- Class Peptides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 18 May 2001 No-Development-Reported for Transplant rejection in Japan (Unknown route)
- 23 Mar 1998 New profile
- 23 Mar 1998 Preclinical development for Transplant rejection in Japan (Unknown route)